DocDollars

Daiichi Sankyo Company Ltd

Japan · Reporting entity ID 100000000056

Total reported 2019–2025
$56.2M
#157 of 2,960 reporting companies — 0.1% of all reported industry payments
$1.74M in general payments across 236 records, plus $54.4M in research funding across 1,501 records.

How it breaks down

General payments $1,743,780
Research funding $54,440,176

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Daiichi Sankyo Company Ltd reported $56.2M to US doctors and teaching hospitals from 2019 to 2025, ranking #157 of 2,960 reporting companies. 97% of that was research funding and 3% general payments such as consulting, speaking, food and travel. 236 general payment records and 1,501 research records were filed.

Common questions about Daiichi Sankyo Company Ltd

How much has Daiichi Sankyo Company Ltd paid US doctors?

Daiichi Sankyo Company Ltd reported $56,183,956 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,743,780 in general payments, $54,440,176 in research funding.

How does Daiichi Sankyo Company Ltd rank among drug and device companies?

It ranks #157 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Daiichi Sankyo Company Ltd mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.